In 2009, a European study of thousands of men found that the PSA screening for prostate cancer reduced the risk of a man’s dying from prostate cancer from 3.0 percent to 2.4 percent. “But it’s already a small risk. I don’t think a difference of less than 1 percent would be of practical importance,” said Ed. Do you agree with Ed’s conclusion? Explain.